This is a package that combines diabetes treatment with stem cells and exosomes, along with cancer prevention through gene protein therapy. Depending on the patient's diabetes condition, oral medication may also be administered.

First Day (Week 0): Fat tissue is harvested from the abdomen and sent to the culture center. Intravenous administration of 2V exosomes and 8 units of gene protein.
Second Session (4 weeks later): Intravenous administration of 100 million stem cells and 2V exosomes.
Third Session (8 weeks later): Intravenous administration of 8 units of gene protein and 2V exosomes.
Fourth Session (16 weeks later): Intravenous administration of 8 units of gene protein and 2V exosomes.
Fifth Session (24 weeks later): Intravenous administration of 100 million stem cells and 2V exosomes.
Depending on the patient's diabetes condition, oral medication may also be prescribed. Urgent blood tests, including blood glucose levels, HbA1c, triglycerides, uric acid levels, and kidney function, are conducted at each visit. There have been several reports of diabetes improvement with stem cells or exosomes, and the clinic director has extensive experience in this treatment. Additionally, there is evidence of cancer prevention through gene protein administration.

Providing Medical Institution

GRAND ETERNITY Ginza Clinic

〒104-0061
10th Floor, Kirarito Ginza, 1-8-19, Ginza, Chuo-Ku,

Specialty

We offer cancer gene therapy for the treatment of various cancers such as lung cancer, pancreatic cancer, gallbladder cancer, colorectal cancer, stomach cancer, breast cancer, and uterine cancer.
Our stem cell and exosome therapies are employed to address conditions including diabetes, chronic kidney disease, rheumatoid arthritis, dementia, and menopausal symptoms.
Furthermore, through our stem cell and exosome therapies, we can also achieve anti-aging benefits and enhance male function.

Eligibility Criteria/Exclusions for Treatment

Patients with diabetes or those suspected of having diabetes who wish to prevent cancer.